Back to
STIFEL FINANCIAL CORP
AXSM
Showing 5 of 17 quarters
Position history for
STIFEL FINANCIAL CORP's holdings in AXSOME THERAPEUTICS INC.
Yes. Stifel Financial holds 7,421 shares of AXSM (Axsome Therapeutics), worth $1.8M, as of its Q2 2026 13F filing. It increased the position by 1,501 shares (+25.4%) from Q1 2026. Stifel Financial has held AXSM since Q2 2025, across 5 quarterly 13F filings.
Current Value
$1.8M
Current Shares
7,421
Total Value Change
+$1.4M
Total Shares Change
+3,099
Quarter-by-Quarter History